Oxygen Administration and Airway Management
Applies to adult and pediatric patients
Criteria
- Providers may operate as outlined below. They may not exceed their scope of practice, even with direct online medical control.
All levels
- Ongoing assessment of the effectiveness of breathing
- See as necessary Extremis: Respiratory Arrest / Failure – Adult or Extremis: Respiratory Arrest / Failure – Pediatric
- Oxygen therapy via non-rebreather mask 10-15 LPM, or nasal cannula 2-6 LPM, to maintain oxygen saturation if saturation is <92% or to effectively manage other signs of dyspnea
- Some children with cardiac conditions may have baseline oxygen saturations between 65 and 85% rather than above 92% (ask care provider about patient’s usual oxygen saturation level)
- Infant oxygen administration, if needed, should be provided at 0.5-2 LPM via appropriately sized nasal cannula
- Any patient with suspected carbon monoxide poisoning should receive high flow oxygen via non-rebreather mask, see General: Carbon Monoxide Exposure – Suspected
- Oxygen therapy using bag-valve-mask 15-25 LPM
- Appropriate BLS airway adjuncts
- Bag-valve-mask assisted ventilation
EMT and up
- Oxygen powered nebulizer devices for use in accordance with manufacturer specifications (typically ~6-8 LPM)
- Supraglottic airway placement‡ in cardiac arrest patients (as regionally approved)
- Consider PEEP 5 cm H2O titrated up to 10 cm H2O
- Portable automated transport ventilators (ATV)‡
- See Resource: Automatic Transport Ventilator
Medical control
- Additional PEEP >10 cm H2O provided MAP maintained >65 mmHg
Key points
- Oxygen should be titrated to maintain saturation at or just above 92% and/or to treat signs of dyspnea. If there is a situation in which the patient may be unstable and hypoxia might be missed (such as major trauma), it is acceptable to place the patient on high flow oxygen.
- Blow-by oxygen administration may be required in some cases
- Providers may only place a supraglottic airway if they utilize waveform capnography for initial and ongoing monitoring of airway patency